Se rendre au contenu

Gentaur Nivolumab – Anti-PD-1 Antibody

https://research.gentaur.com/web/image/product.template/472746/image_1920?unique=02640f7
(0 avis)
A research-grade biosimilar to nivolumab, targeting PD-1. Used in tumor immunology, TIL analysis, and immune modulation.

1.234.567,00 € 1234567.0 EUR 1.234.567,00 € Hors taxes

1.234.567,00 € Hors taxes

Not Available For Sale

Cette combinaison n'existe pas.

Conditions générales
Garantie satisfait ou remboursé de 30 jours
Expédition : 2-3 jours ouvrables

Our latest content

Check out what's new in our company !

Your Dynamic Snippet will be displayed here... This message is displayed because you did not provide both a filter and a template to use.